Avrohn Pharma (I) Limited

Pharmaceutical company involved in trading, manufacturing, and distribution of drugs and medicines.

2012 | Delhi (India) | Active
Last Updated:

Avrohn Pharma (I) Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.48 Cr
  • Satisfied Charges ₹ 6.00 M
  • Revenue Growth 32.98%
  • Profit Growth 5.88%
  • Ebitda -9.11%
  • Net Worth 32.87%
  • Total Assets 22.75%

About Avrohn Pharma (I)

Avrohn Pharma (I) Limited (APIL) is a Public Limited Indian Non-Government Company incorporated in India on 12 March 2012 and has a history of 13 years and two months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.

The company currently has active open charges totaling ₹2.48 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.

Neeta Gupta, Virender Gupta, and Abhishek Gupta serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24119DL2012PLC232680

  • Company No.

    232680

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    12 Mar 2012

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Avrohn Pharma (I) Limited

Explore comprehensive data for Avrohn Pharma (I) Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Avrohn Pharma (I)?

Board Members (3)

NameDesignationAppointment DateStatus
Neeta Gupta Country flag representing In Director 26-Mar-2022Current
Virender Gupta Country flag representing In Director 12-Mar-2012Current
Abhishek Gupta Country flag representing In Director 12-Mar-2012Current

Financial Performance of Avrohn Pharma (I).

Avrohn Pharma (I) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.98% increase. The company also saw a slight improvement in profitability, with a 5.88% increase in profit. The company's net worth Soared by an impressive increase of 32.87%.

Avrohn Pharma (I) revenue growth over time
Avrohn Pharma (I) profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
32.98%
Revenue from Operations
32.98%
Total Assets
22.75%
Profit or Loss
5.88%
Net Worth
32.87%
EBITDA
-9.11%

What is the Ownership and Shareholding Structure of Avrohn Pharma (I)?

In 2022, Avrohn Pharma (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹24.80 M

Satisfied Charges

₹6.00 M

Charges Breakdown by Lending Institutions

  • Canara Bank : 2.48 Cr

Latest Charge Details

DateLenderAmountStatus
06 Feb 2024Canara Bank₹1.90 MOpen
06 Nov 2023Canara Bank₹1.95 CrOpen
19 Oct 2019Canara Bank₹0.90 MOpen
10 Aug 2017Canara Bank₹2.50 MOpen
28 Sep 2022Hdfc Bank Limited₹6.00 MSatisfied

How Many Employees Work at Avrohn Pharma (I)?

Unlock and access historical data on people associated with Avrohn Pharma (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Avrohn Pharma (I) Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avrohn Pharma (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avrohn Pharma (I)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Avrohn Pharma (I)

Recent activity within the organization

  • Annual General Meeting

    Avrohn Pharma (I) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge registered on 28 Sep 2022 via Charge ID 100676073 with Hdfc Bank Limited was fully satisfied on 24 Sep 2024.

  • Charges

    A charge with Canara Bank of Rs. 19.50 M registered on 06 Nov 2023 with Charge ID 100817488 was modified on 10 Sep 2024.

  • Balance Sheet

    Avrohn Pharma (I) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Charges

    A charge with Canara Bank amounted to Rs. 1.90 M with Charge ID 100874919 was registered on 06 Feb 2024.

  • Charges

    A charge with Canara Bank amounted to Rs. 19.50 M with Charge ID 100817488 was registered on 06 Nov 2023.

Frequently asked questions

  • What is the Incorporation or founding date of Avrohn Pharma (I) Limited?

    Avrohn Pharma (I) Limited was incorporated on 12 Mar 2012.

  • What is authorized share capital and paid-up capital of Avrohn Pharma (I) Limited?

    The authorized share capital of Avrohn Pharma (I) Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Avrohn Pharma (I) Limited?

    Currently 3 directors are associated with Avrohn Pharma (I) Limited.

    • Neeta Verender Kumar Gupta
    • Virender Kumar Gupta
    • Abhishek Gupta

  • What is the registered address of Avrohn Pharma (I) Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Avrohn Pharma (I) Limited is G-216 Hall No. 1 Ground Floor Dakka Village Near Kingsway Camp, India, Delhi, 110009.

  • What is the corporate identification number (CIN) and company number of Avrohn Pharma (I) Limited?

    The corporate identification number (CIN) of Avrohn Pharma (I) Limited is U24119DL2012PLC232680 and the company number is 232680 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Avrohn Pharma (I) Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Avrohn Pharma (I) Limited has risen by 32.98%.

  • What change has been observed in the net worth of Avrohn Pharma (I) Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Avrohn Pharma (I) Limited has experienced an upsurge of 32.87%.

  • What are the total open charges for Avrohn Pharma (I) Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Avrohn Pharma (I) Limited amount to ₹ 2.48 Cr.

  • When was the last Balance Sheet of Avrohn Pharma (I) Limited filed with the ROC?

    The most recent Balance Sheet for Avrohn Pharma (I) Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors